| http://dbpedia.org/ontology/abstract
|
BioMarin Pharmaceutical ist ein US-amerika … BioMarin Pharmaceutical ist ein US-amerikanisches Biotechnologieunternehmen mit Hauptsitz in San Rafael, Kalifornien. Es verfügt über Niederlassungen und Einrichtungen in den USA, Südamerika, Asien und Europa. Das Unternehmen ist spezialisiert auf lebensbedrohliche und seltene genetische Krankheiten. Das Kerngeschäft und das hauptsächliche Forschungsfeld von BioMarin sind Enzymersatztherapien. BioMarin war das erste Unternehmen, das Therapeutika für Mukopolysaccharidose Typ I (MPS I) durch Herstellung von Iduronidase (Aldurazyme, vertrieben von Genzyme Corporation) anbot. BioMarin war auch das erste Unternehmen, das Therapeutika gegen Phenylketonurie (PKU) anbot. Ein weiterer Fokus von BioMarin ist die Gentherapie. So untersucht das Unternehmen seit Jahren die Option, die Hämophilie (Bluterkrankheit) mithilfe dieses Therapieprinzips zu behandeln. Im Unterschied zur konventionellen Therapie, die eine lebenslange Behandlung erfordert, würde die – einmalige – Gentherapie eine Heilung herbeiführen. Noch ist diese aber definitiv noch nicht zugelassen!iese aber definitiv noch nicht zugelassen!
, BioMarin Pharmaceutical Inc. is an America … BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU). Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.enying access to drugs in clinical trials.
, BioMarin Pharmaceutical est une entreprise de biotechnologie américaine produisant notamment la tétrahydrobioptérine et l'amifampridine. Elle est basée à Novato en Californie.
, 拜玛林制药（英語：BioMarin Pharmaceutical Inc.）是一家总部位于美国加州聖拉菲爾的跨国制药公司，主要研究、生产相关药物。此公司发明的是最早出现的I型黏多醣症治疗药物。 该公司由克里斯托佛·斯塔尔（Christopher Starr）和小格兰特·丹尼森（Grant W. Denison Jr.）创立于1997年，1999年上市。
|
| http://dbpedia.org/ontology/assets
|
5.848E9
|
| http://dbpedia.org/ontology/equity
|
4.106E9
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/San_Rafael%2C_California +
|
| http://dbpedia.org/ontology/netIncome
|
8.59E8
|
| http://dbpedia.org/ontology/numberOfEmployees
|
2581
|
| http://dbpedia.org/ontology/operatingIncome
|
3.6765E7
|
| http://dbpedia.org/ontology/revenue
|
1.86E9
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/BioMarin_logo.svg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageID
|
4136144
|
| http://dbpedia.org/ontology/wikiPageLength
|
19374
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1109271013
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Stephen_Hammond +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Adeno-associated_virus +
, http://dbpedia.org/resource/Category:Technology_companies_based_in_the_San_Francisco_Bay_Area +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/PKU +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Repligen +
, http://dbpedia.org/resource/Achondroplasia +
, http://dbpedia.org/resource/Orphan_drug +
, http://dbpedia.org/resource/Category:1999_initial_public_offerings +
, http://dbpedia.org/resource/Phenylketonuria +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1997 +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/European_Commission +
, http://dbpedia.org/resource/Elosulfase_alfa +
, http://dbpedia.org/resource/Enzyme_replacement_therapy +
, http://dbpedia.org/resource/National_Health_Service +
, http://dbpedia.org/resource/Iduronidase +
, http://dbpedia.org/resource/Lambert%E2%80%93Eaton_myasthenic_syndrome +
, http://dbpedia.org/resource/Batten_disease +
, http://dbpedia.org/resource/Asia +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Orphan_drug_companies +
, http://dbpedia.org/resource/Amifampridine +
, http://dbpedia.org/resource/Category:American_companies_established_in_1997 +
, http://dbpedia.org/resource/PARP_inhibitor +
, http://dbpedia.org/resource/Haemophilia_A +
, http://dbpedia.org/resource/Preliminary_injunction +
, http://dbpedia.org/resource/Small_molecule +
, http://dbpedia.org/resource/San_Rafael%2C_California +
, http://dbpedia.org/resource/Arylsulfatase_B +
, http://dbpedia.org/resource/Neuronal_ceroid_lipofuscinosis +
, http://dbpedia.org/resource/Recombinant_protein +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:1997_establishments_in_California +
, http://dbpedia.org/resource/Legal_proceeding +
, http://dbpedia.org/resource/Chemical_library +
, http://dbpedia.org/resource/Morquio_syndrome +
, http://dbpedia.org/resource/Aldurazyme +
, http://dbpedia.org/resource/Expanded_access +
, http://dbpedia.org/resource/Friedreich%27s_ataxia +
, http://dbpedia.org/resource/Valoctocogene_roxaparvovec +
, http://dbpedia.org/resource/Vimizim +
, http://dbpedia.org/resource/Amifampridine_Phosphate +
, http://dbpedia.org/resource/Naglazyme +
, http://dbpedia.org/resource/Palynziq +
, http://dbpedia.org/resource/Firdapse +
, http://dbpedia.org/resource/3%2C4-diaminopyridine +
, http://dbpedia.org/resource/Kuvan_%28drug%29 +
, http://dbpedia.org/resource/Phase_1_clinical_trial +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Rafael%2C_California +
, http://dbpedia.org/resource/Russell_1000 +
, http://dbpedia.org/resource/Cerliponase_alfa +
, http://dbpedia.org/resource/Factor_VIII +
, http://dbpedia.org/resource/Brineura +
, http://dbpedia.org/resource/Reimbursement +
, http://dbpedia.org/resource/Histone_deacetylase_inhibitor +
, http://dbpedia.org/resource/Europe +
, http://dbpedia.org/resource/Category:Virotherapy +
, http://dbpedia.org/resource/South_America +
, http://dbpedia.org/resource/Vosoritide +
, http://dbpedia.org/resource/Maroteaux%E2%80%93Lamy_syndrome +
, http://dbpedia.org/resource/Mucopolysaccharidosis +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
, http://dbpedia.org/resource/Prosensa +
, http://dbpedia.org/resource/Tetrahydrobiopterin +
, http://dbpedia.org/resource/Genzyme +
, http://dbpedia.org/resource/Duchenne_muscular_dystrophy +
, http://dbpedia.org/resource/US%24 +
|
| http://dbpedia.org/property/assets
|
5.848E9
|
| http://dbpedia.org/property/equity
|
4.106E9
|
| http://dbpedia.org/property/google
|
BMRN
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/location
|
San Rafael, California, U.S.
|
| http://dbpedia.org/property/logo
|
BioMarin logo.svg
|
| http://dbpedia.org/property/name
|
BioMarin Pharmaceutical Inc.
|
| http://dbpedia.org/property/netIncome
|
8.59E8
|
| http://dbpedia.org/property/numEmployees
|
2581
|
| http://dbpedia.org/property/operatingIncome
|
–US$36.765 Million
|
| http://dbpedia.org/property/revenue
|
1.86E9
|
| http://dbpedia.org/property/secCik
|
BMRN
|
| http://dbpedia.org/property/symbol
|
BMRN
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Url +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:Start_date_and_age +
, http://dbpedia.org/resource/Template:Clade +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Small +
, http://dbpedia.org/resource/Template:Finance_links +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Ubl +
|
| http://dbpedia.org/property/yahoo
|
BMRN
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Technology_companies_based_in_the_San_Francisco_Bay_Area +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Rafael%2C_California +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:1999_initial_public_offerings +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:1997_establishments_in_California +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:Orphan_drug_companies +
, http://dbpedia.org/resource/Category:Virotherapy +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:American_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.422932.c +
, http://www.grid.ac/institutes/grid.476101.5 +
, http://www.grid.ac/institutes/grid.476103.7 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/BioMarin_Pharmaceutical?oldid=1109271013&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/BioMarin_logo.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/BioMarin_Pharmaceutical +
|
| http://xmlns.com/foaf/0.1/name
|
BioMarin Pharmaceutical Inc.
|
| owl:sameAs |
http://fa.dbpedia.org/resource/%D8%A8%D8%A7%DB%8C%D9%88%D9%85%D8%B1%DB%8C%D9%86 +
, http://rdf.freebase.com/ns/m.0bl0xp +
, http://yago-knowledge.org/resource/BioMarin_Pharmaceutical +
, https://global.dbpedia.org/id/4YkVV +
, http://de.dbpedia.org/resource/BioMarin_Pharmaceutical +
, http://www.wikidata.org/entity/Q4914632 +
, http://et.dbpedia.org/resource/BioMarin_Pharmaceutical +
, http://dbpedia.org/resource/BioMarin_Pharmaceutical +
, http://zh.dbpedia.org/resource/%E6%8B%9C%E7%91%AA%E6%9E%97%E8%A3%BD%E8%97%A5 +
, http://fr.dbpedia.org/resource/BioMarin_Pharmaceutical +
|
| rdf:type |
http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/WikicatTechnologyCompaniesBasedInTheSanFranciscoBayArea +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnNASDAQ +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/WikicatCompaniesInTheNASDAQBiotechnologyIndex +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://schema.org/Organization +
|
| rdfs:comment |
BioMarin Pharmaceutical Inc. is an America … BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).de therapeutics for phenylketonuria (PKU).
, 拜玛林制药（英語：BioMarin Pharmaceutical Inc.）是一家总部位于美国加州聖拉菲爾的跨国制药公司，主要研究、生产相关药物。此公司发明的是最早出现的I型黏多醣症治疗药物。 该公司由克里斯托佛·斯塔尔（Christopher Starr）和小格兰特·丹尼森（Grant W. Denison Jr.）创立于1997年，1999年上市。
, BioMarin Pharmaceutical ist ein US-amerika … BioMarin Pharmaceutical ist ein US-amerikanisches Biotechnologieunternehmen mit Hauptsitz in San Rafael, Kalifornien. Es verfügt über Niederlassungen und Einrichtungen in den USA, Südamerika, Asien und Europa. Das Unternehmen ist spezialisiert auf lebensbedrohliche und seltene genetische Krankheiten. Das Kerngeschäft und das hauptsächliche Forschungsfeld von BioMarin sind Enzymersatztherapien. BioMarin war das erste Unternehmen, das Therapeutika für Mukopolysaccharidose Typ I (MPS I) durch Herstellung von Iduronidase (Aldurazyme, vertrieben von Genzyme Corporation) anbot. BioMarin war auch das erste Unternehmen, das Therapeutika gegen Phenylketonurie (PKU) anbot.peutika gegen Phenylketonurie (PKU) anbot.
, BioMarin Pharmaceutical est une entreprise de biotechnologie américaine produisant notamment la tétrahydrobioptérine et l'amifampridine. Elle est basée à Novato en Californie.
|
| rdfs:label |
BioMarin Pharmaceutical
, 拜瑪林製藥
|
